Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Either the symbol is incorrect or we do not track estimates for this company
Ranking History
Headlines
- China Sky One Has Another 26 Products Awaiting Approval
Sep 10, 2008 01:54 PM
- China Sky One’s Quarter 2 Beats Estimates
Aug 13, 2008 10:07 AM
- China Sky One Reports 11 Drugs in Clinical Trials
Jul 11, 2008 02:38 PM
- China Sky One to Launch Clot Buster Injection
Jul 08, 2008 02:36 PM
- China Sky One Receives Four More Approvals
Jun 19, 2008 02:49 AM
- ChinaBio: Week in Review: Deals and Drugs
Jun 15, 2008 03:47 PM
- China Sky One Makes $7 Million Acquisition
Jun 12, 2008 02:19 PM
- Some Potential Shorts & Advice
Jun 11, 2008 12:00 PM
- China Sky One Ups Forecast; Hits New High
Jun 10, 2008 01:51 PM
- China Sky One Granted Five Approvals
Jun 03, 2008 05:16 PM
- China Sky One Medical, Inc. Completes Acquisition of Peng Lai Jin Chuang Company
Sep 11, 2008 04:25 PM
- China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
Sep 10, 2008 08:02 AM
- Analyst Reports for Taseko Mines Limited, Hanover Capital Mortgage Holdings Inc., Tanzanian Royalty Exploration Corporation and China Sky One Medical Inc.
Sep 08, 2008 01:07 PM
- China Sky One Medical, Inc. to Present at SIG Beijing Management Summit
Sep 08, 2008 08:02 AM
- China Sky One Medical Announces Successful Marketing Campaign
Sep 04, 2008 08:03 AM
- China Sky One Medical, Inc. Approved to List on the NASDAQ Global Market
Sep 02, 2008 03:00 PM
- China Sky One Medical, Inc. Develops Nasal Spray for Rheumatic Disease
Aug 14, 2008 08:01 AM
- China Sky One Medical, Inc. Announces Record Second Quarter 2008 Results
Aug 12, 2008 08:04 AM
- /C O R R E C T I O N -- China Sky One Medical, Inc./
Jul 16, 2008 09:23 PM
- China Sky One Medical, Inc. Signs Distribution Agreement with Harbin Baolong Pharmaceutical Company
Jul 15, 2008 03:29 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
CSY
|
Compare to S&P
|
| YTD |
-0.01 %
|
-0.01 %
|
| 4 Weeks |
-12.88 %
|
-9.64 %
|
| 12 Weeks |
-6.39 %
|
-1.44 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -0.01 %
|
|
EPS Growth in Last Year: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
|
